F

Forte Biosciences
D

FBRX

9.62000
USD
-0.47
(-4.66%)
مغلق
حجم التداول
2,055
الربح لكل سهم
-5
العائد الربحي
-
P/E
-1
حجم السوق
117,497,064
أصول ذات صلة
AZN
AZN
0.880
(1.20%)
73.960 USD
BMY
BMY
0.885
(2.04%)
44.225 USD
GSK
GSK
0.402
(1.08%)
37.557 USD
LLY
LLY
22.87
(3.09%)
762.54 USD
MRK
MRK
1.157
(1.48%)
79.300 USD
NVO
NVO
1.135
(2.41%)
48.185 USD
NVS
NVS
1.540
(1.35%)
115.280 USD
PFE
PFE
0.185
(0.79%)
23.470 USD
SNY
SNY
1.115
(2.44%)
46.765 USD
V
VTRS
0.07500
(0.86%)
8.80500 USD
المزيد
الأخبار المقالات

العنوان: Forte Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).